CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
2015 ◽
2013 ◽
Vol 49
(7)
◽
pp. 1539-1545
◽
2010 ◽
Vol 8
(3)
◽
pp. 231-232
2014 ◽
Vol 7
(1)
◽
pp. 20-28
◽
2018 ◽
Vol 17
(4)
◽
pp. 275
◽
1999 ◽
Vol 79
(3-4)
◽
pp. 478-482
◽
2005 ◽
Vol 7
(5)
◽
pp. 369-376
◽
Keyword(s):